Global Lung Cancer Mortality Trends and Lifestyle Modifications: A Comprehensive Look
Lung cancer is a global health concern, claiming the lives of 1.6 million people each year and accounting for 19.4% of cancer-related deaths. While treatment options for advanced lung cancer are limited, prevention through lifestyle modifications is a key focus. This article explores the relationship between lifestyle changes, as promoted by the World Health Organization (WHO), and lung cancer mortality trends.
The Burden of Non-Communicable Diseases (NCDs)
NCDs, including cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes, are responsible for 71% of global deaths. Lung cancer is a major contributor to this burden. The WHO has set targets to reduce NCD mortality, including a 30% reduction by 2030 as part of the United Nations Sustainable Development Goal 3.4.
Lung Cancer: A Lethal Disease
Lung cancer is the most common lethal neoplasm worldwide. It has a poor prognosis, with a 5-year survival rate of only about 13% if it has spread to other organs. Lifestyle factors, such as tobacco use, physical inactivity, unhealthy diet, and harmful alcohol use, are known risk factors for lung cancer.
WHO’s Approach to NCD Prevention
The WHO has identified a package of 16 “best buy” interventions for NCD management and lifestyle modification. These include tobacco control, physical activity promotion, healthy diet initiatives, and alcohol reduction measures. Implementing these interventions could potentially reduce NCD mortality.
Analyzing Mortality Trends
Using WHO statistics, the study analyzed lung cancer mortality trends from 2000 to 2016 in 49 countries. It also compared lifestyle modification measures in countries with declining and increasing lung cancer mortality.
Key Findings
- Tobacco Control: The decline in lung cancer mortality was associated with the anti-tobacco campaign initiated by the WHO. In countries with declining mortality, 91% had decreasing tobacco prevalence in males and 82% in females.
- Physical Activity: Country-wide measures to increase physical activity had a strong tendency to be better implemented in countries with declining lung cancer mortality.
- Diet and Alcohol: Other WHO “best-buy” lifestyle modification campaigns (diet and alcohol) had been carried out for shorter periods, and their associations with lung cancer were less strong than tobacco. There was no significant difference in harmful alcohol use reduction measures and unhealthy diet reduction measures between countries with declining and increasing lung cancer mortality.
Discussion
- Tobacco Cessation: Tobacco cessation remains the overarching strategy for lung cancer prevention. Public health programs that reduce smoking are effective, but more efforts are needed, especially in countries where smoking is increasing.
- Physical Activity: Promoting physical activity can have a positive impact on lung cancer mortality. WHO’s global recommendations on physical activity for health should be adapted and translated into culturally appropriate forms at the country level.
- Diet and Alcohol: While the correlation between diet and lung cancer is less obvious compared with tobacco, emphasis should be placed on a healthy diet as part of lifestyle changes. More research is needed to determine the role of alcohol in lung cancer etiology.
- Air Pollution: Indoor and outdoor air pollution are also risk factors for lung cancer. However, the study did not find a significant difference in air pollution levels between countries with declining and increasing lung cancer mortality.
Conclusion
Following WHO “best buys” can help countries move towards NCD mortality reduction targets, including lung cancer. Governments and communities must embrace these targets with coordinated effective action. Strengthening commitments to tobacco restrictions, physical activity promotion, healthy diet, and alcohol reduction will contribute to better health outcomes. More research is needed to further understand the complex relationship between lifestyle factors and lung cancer and to develop more effective prevention strategies.
[1] World Health Organization. Noncommunicable Diseases Country Profiles 2018. Geneva: World Health Organization, 2018. [2] Global Action Plan for the Prevention and Control of Non-communicable Diseases 2013–2020. Geneva: World Health Organization, 2013. Available from: http://www.who.int/nmh/events/ncd_action_plan/en/. [Accessed August 16, 2018] [3] Thirteenth General Programme of Work, 2019–2023. Geneva: World Health Organization, 2018. Available from: http://www.who.int/about/what-wedo/gpw-thirteen-consultation/en/. [Accessed August 16, 2018] [4] World Health Assembly Resolution WHA71.1. Thirteenth General Programme of Work, 2019–2023. Geneva: World Health Organization, 2018. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA71/A71_R1-en.pdf. [Accessed August 16, 2018] [5] Transforming Our World: the 2030 Agenda for Sustainable Development. New York: United Nations, 2015. Available from: https://www.un.org/development/desa/dspd/2015/08/transforming-our-world-the-2030-agenda-for-sustainable-development/. [Accessed August 16, 2018] [6] United Nations General Assembly Resolution A/RES/70/1. Transforming our world: the 2030 Agenda for Sustainable Development. New York: United Nations, 2015. Available from: http://www.un.org/ga/search/view_doc.asp?symbol=A/RES/70/1&Lang=E. [Accessed August 16, 2018] [7] Time to Deliver: Report of the WHO Independent High-Level Commission on Noncommunicable Diseases. Geneva: World Health Organization, 2018. Available from: http://www.who.int/iris/handle/10665/272710. [Accessed June 1, 2018] [8] Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000–2016. Geneva: World Health Organization, 2018. Available from: http://www.who.int/healthinfo/global_burden_disease/estimates/en/. [Accessed November 30, 2018] [9] Willett WC, Trichopoulos D. Nutrition and cancer: a summary of the evidence. Cancer Causes Control 1996;7:178–180. doi: 10.1007/bf00115648. [10] Forum of International Respiratory Societies. The Global Impact of Respiratory Disease-Second Edition. Sheffield: European Respiratory Society, 2017. [11] Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87–108. doi: 10.3322/caac.21262. [12] Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:706–714. doi: 10.1097/JTO.0-b013e31812f3c1a. [13] Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P. Risk factors for lung cancer worldwide. Eur Respir J 2016;48:889–902. doi: 10.1183/13993003.00359-2016. [14] World Health Organization. Global Status Report on Noncommunicable Diseases 2010. Geneva: World Health Organization, 2011. [15] Tackling NCDs. “Best Buys” and Other Recommended Interventions for the Prevention and Control of Noncommunicable Diseases. Geneva: World Health Organization, 2017. Available from: https://www.who.int/publications/i/item/WHO-NMH-NVI-17.9. [Accessed August 16, 2018] [16] Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med 2011;32:605–644. doi: 10.1016/j.ccm.2011.09.001. [17] Khaltaev N. WHO dietary recommendations and prevention of chronic respiratory diseases. J Obes Nutr Disord 2018. doi: 10.29011/2577-2244.100025. [18] New Country Classifications by Income Level: 2018-2019. Available from: https://blogs.worldbank.org/opendata/new-country-classifications-income-level-2018-2019. [Accessed August 8, 2019] [19] World Health Organization. Noncommunicable Diseases Progress Monitor 2017. Geneva: World Health Organization, 2017. [20] Khaltaev N. GARD, a new way to battle with chronic respiratory diseases, from disease oriented programmes to global partnership. J Thorac Dis 2017;9:4676–4689. doi: 10.21037/jtd.2017.11.91. [21] Global Status Report on Noncommunicable Diseases 2014. Geneva: World Health Organization, 2014. Available from: http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf?ua=1. [Accessed July 18, 2015] [22] World Health Organization. Noncommunicable Diseases Progress Monitor 2020. Geneva: World Health Organization, 2020. [23] Loomis D, Huang W, Chen G. The International Agency for Research on Cancer (IARC) evaluation of the carcinogenicity of outdoor air pollution: focus on China. Chin J Cancer 2014;33:189–196. doi: 10.5732/cjc.014.10028. [24] International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 95. Household Use of Solid Fuels and High-temperature. Frying, Lyon: World Health Organization/IARC, 2010. [25] Lissowska J, Bardin-Mikolajczak A, Fletcher T, Zaridze D, Szeszenia-Dabrowska N, Rudnai P, et al. Lung cancer and indoor pollution from heating and cooking with solid fuels: the IARC international multicentre case-control study in Eastern/Central Europe and the United Kingdom. Am J Epidemiol 2005;162:326–333. doi: 10.1093/aje/kwi204. [26] Global Recommendations on Physical Activity for Health. Geneva: World Health Organization, 2010. Available from: http://www.who.int/dietphysicalactivity/publications/9789241599979/en/. [Accessed August 16, 2018] [27] Vieira AR, Abar L, Vingeliene S, Chan DS, Aune D, Navarro-Rosenblatt D, et al. Fruits, vegetables and lung cancer risk: a systematic review and meta-analysis. Ann Oncol 2016;27:81–96. doi: 10.1093/annonc/mdv381. [28] Mori N, Shimazu T, Sasazuki S, Nozue M, Mutoh M, Sawada N, et al. Cruciferous vegetable intake is inversely associated with lung cancer risk among current nonsmoking men in the Japan Public Health Center (JPHC) study. J Nutr 2017;147:841–849. doi: 10.3945/jn.117.247494. [29] Zhang Z, Bergan R, Shannon J, Slatore CG, Bobe G, Takata Y. The role of cruciferous vegetables and isothiocyanates for lung cancer prevention: current status, challenges, and future research directions. Mol Nutr Food Res 2018;62:e1700936. doi: 10.1002/mnfr.201700936. [30] Yu N, Su X, Wang Z, Dai B, Kang J. Association of dietary vitamin A and b-carotene Intake with the risk of lung cancer: a meta-analysis of 19 publications. Nutrients 2015;7:9309–9324. doi: 10.3390/nu7115463. [31] Luu HN, Cai H, Murff HJ, Xiang YB, Cai Q, Li H, et al. A prospective study of dietary polyunsaturated fatty acids intake and lung cancer risk. Int J Cancer 2018;143:2225–2237. doi: 10.1002/ijc.31608. [32] Smith-Warner SA, Ritz J, Hunter DJ, Albanes D, Beeson WL, van den Brandt PA, et al. Dietary fat and risk of lung cancer in a pooled analysis of prospective studies. Cancer Epidemiol Biomarkers Prev 2002;11:987–992. [33] Bagnardi V, Rota M, Botteri E, Scotti L, Jenab M, Bellocco R, et al. Alcohol consumption and lung cancer risk in never smokers: a meta-analysis. Ann Oncol 2011;22:2631–2639. doi: 10.1093/annonc/mdr027. [34] Bandera EV, Freudenheim JL, Vena JE. Alcohol consumption and lung cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 2001;10:813–821. [35] Korte JE, Brennan P, Henley SJ, Boffetta P. Dose-specific meta-analysis and sensitivity analysis of the relation between alcohol consumption and lung cancer risk. Am J Epidemiol 2002;155:496–506. doi: 10.1093/aje/155.6.496. [36] Freudenheim JL, Ritz J, Smith-Warner SA, Albanes D, Bandera EV, van den Brandt PA, et al. Alcohol consumption and risk of lung cancer: a pooled analysis of cohort studies. Am J Clin Nutr 2005;82:657–667. doi: 10.1093/ajcn.82.3.657.
doi: 10.1097/CM9.0000000000000918
Was this helpful?
0 / 0